Navigation Links
Purdue proves concept of using nano-materials for drug discovery

Researchers at Purdue University have built and demonstrated a prototype for a new class of miniature devices to study synthetic cell membranes in an effort to speed the discovery of new drugs for a variety of diseases, including cancer.

The researchers created a chip about one centimeter square that holds thousands of tiny vessels sitting on top of a material that contains numerous pores. This "nanoporous" material makes it possible to carry out reactions inside the vessels.

The goal is to produce "laboratories-on-a-chip" less than a half-inch square that might contain up to a million test chambers, or "reactors," each capable of screening an individual drug, said Gil Lee, the project's leader and an associate professor of chemical engineering.

"What we are reporting now is a proof of concept," said Lee, one of three researchers who wrote a paper that details new findings in the current issue (Feb. 15) of the journal Langmuir. The two other researchers are Zhigang Wang, a postdoctoral fellow at Purdue; and Richard Haasch, a research scientist at the University of Illinois at Urbana-Champaign.

The work is part of overall research being carried out by an interdisciplinary team of scientists and engineers who are members of a Center for Membrane Protein Biotechnology. The center was created at Purdue in 2003 through a grant from the Indiana 21st Century Research and Technology Fund, established by the state of Indiana to promote high-tech research and to help commercialize innovations.

The vessels discussed in the research paper are cylindrical cavities that are open at the top and sealed at the bottom with a material called alumina, which contains numerous pores measured in nanometers, or billionths of a meter.

Researchers are working to duplicate how cell membranes function on chips in order to test the potential effectiveness of new drugs to treat diseases. Membranes, which surround cells and regulate the movement of m
'"/>

Source:Purdue University


Page: 1 2 3

Related biology news :

1. Purdue researchers use enzyme to clip DNA wires
2. Purdue scientists may have found key to halting spinal cord damage
3. Purdue researchers find key to rice blast fungus
4. Purdues gold nanorods brighten future for medical imaging
5. Purdue creates new low-cost system to detect bacteria
6. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
7. FDA Approves Human Hookworm Vaccine for Phase I Safety Trials
8. FDA Approves New Drug to Treat Type I and Type II Diabetes
9. Canada approves marijuana-based pain spray
10. Bevacizumab Combined With Chemotherapy Improves Progression-Free Survival for Patients With Advanced Breast Cancer
11. Product improves peptide identification for proteomics research

Post Your Comments:
(Date:11/20/2009)... November 2009 issue of the journal GENETICS ( h...mily of genes (1-aminocyclopropane-1-carboxylate s...ion of ethylene. This gas affects many aspects of ...oundation for future genetic manipulation that cou...and thrive in difficult terrain, increase yields, ...
(Date:11/20/2009)...f Oklahoma researchers were sequencing the first h...t. Today, the OU Advanced Center for Genome Tech...to sequence the tomato genome with a $7.5 million ...or plant genomics. , "The tomato has tremendous...nd crop yields will improve quality of life," said...
(Date:11/20/2009)...ological molecules like RNA and DNA is how they fi...e precursors. Now, in a study appearing in this we...one of the earliest evolutionary steps yet: genera...sing nothing but warm water. , Many researchers...molecules present, before DNA and proteins; howeve...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Shorter More Intense Radiation OK for Some Breast Cancers 60701 1Shorter More Intense Radiation OK for Some Breast Cancers 60701 2Shorter More Intense Radiation OK for Some Breast Cancers 60701 3Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 1Digital divide 3A Psychologists suggest ways to include the aging population in the tech revolution 60698 2OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 1OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 2OU achieves 2410 million in stimulus grants for 33 projects on the Norman campus 10636 3
...archers at the UC Davis M.I.N.D. Institute have fo...ited unusual exploration of objects long before be...h risk for developing autism, the researchers foun...r were more likely to spin, repetitively rotate, s...at simple objects, including a baby bottle and a r...
...s of American adults are aware of the importance o...teps to eat a healthy diet and engage in exercise,...nationwide consumer opinion survey, Nutrition and ...1, ADA has used respondents, answers to a number o...ree groups representing people,s overall attitudes...
...2008 -- Billions of tons of carbon sequestered in ...tmosphere in the coming decades as a result of glo...terplay between peat bogs, water tables, and clima...a small percentage of the carbon locked away in th...de carbon, scientists at Harvard University, Worce...
Other Biology News:Unusual use of toys in infancy a clue to later autism 2Unusual use of toys in infancy a clue to later autism 3American Dietetic Association releases 2008 nutrition trends survey 2Global warming predicted to hasten carbon release from peat bogs 2
(Date:11/19/2009)...wswire-FirstCall/ -- Omeros Corporation (Nasdaq: ... for the third quarter ended September 30, 2009. F...os reported a net loss of $3.9 million, or $1.34 p...n, or $2.54 per share, for the same period in 2008...e Company reported a net loss of $15.5 million, or...
(Date:11/19/2009)...Md., Nov. 19 Spherix Inc...hnology for diabetes therapy, and a provider of te..., supplement, biotechnology and pharmaceutical com...eported $6.3 million registered direct placement t...ts common stock and warrants to purchase up to 1,1...
(Date:11/19/2009)... Spherix Incorporated (N...diabetes therapy, and a provider of technical and ..., biotechnology and pharmaceutical companies, toda...g of Shareholders. ,, At the meeting, sharehold...ed the following members to the Board of Directors...
(Date:11/19/2009)...y, November 19 MONITORING FORCE Gm..., 2009 Flibanserin in the,indication treatment-rel...isease for orphan drug status designation with the...d dyskinesia is a complication of the mainstay,tre...n to some of those,affected, since it may be disab...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...aq:,PURE), creators of the patented antimicrobial,...evenues for the fiscal year ended July 31, 2008 of...ed with $336,400 in the,prior fiscal year. The Com...of $(6,540,300), or $(0.24) per share, compared wi...n the prior year., (Logo: http://www.newscom.com...
...xpanding Industry Connections, MOUNTAINSIDE, N.J....ndependent, full-service medical education company...ice President, Business,Development., Weinstein w...nd,publishing as the head of Business Development....lication Sales at McMahon Publishing., "Todd brin...
...aq:,CPHD) today announced the U.S. Food & Drug Adm...MRSA/SA Skin and Soft Tissue Infection (SSTI) test...atory Improvement Amendments,(CLIA). The new test ...-resistant Staphylococcus aureus (MRSA) and Staphy...tive) in SSTIs. Xpert MRSA/SA SSTI,runs on Cepheid...
Other Biology Technology:PURE Bioscience Reports Fourth Quarter and Year End Results 2PURE Bioscience Reports Fourth Quarter and Year End Results 3PURE Bioscience Reports Fourth Quarter and Year End Results 4PURE Bioscience Reports Fourth Quarter and Year End Results 5PURE Bioscience Reports Fourth Quarter and Year End Results 6PURE Bioscience Reports Fourth Quarter and Year End Results 7L&M Healthcare Communications LLC Expands Client Services With Executive Team Expansion 2Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA 2Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA 3Cepheid Molecular Diagnostic Test for MRSA and S. aureus Categorized 'Moderate Complexity' by FDA 4
Src cDNA Expression Kit (wild type) from Upstate
MagneSil KF, Genomic System from Promega
Chicken Anti-Human ADI1 Polyclonal Antibody, Unconjugated from Abcam
EcoRI-ACA AFLP Amplification Primers from Applied Biosystems
Biology Products: